ORKA – oruka therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ORKA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/13

07:37 am

orka

Rating for ORKA

Medium Report

Rating for ORKA

Report

11/13

07:37 am

orka

Rating for ORKA

Medium Report

Rating for ORKA

Report

11/13

05:04 am

orka

Rating for ORKA

Medium Report

Rating for ORKA

Report

11/13

04:50 am

orka

Oruka Therapeutics initiated with a Buy at Jefferies

Medium Report

Oruka Therapeutics initiated with a Buy at Jefferies

Report

11/13

04:50 am

orka

Oruka Therapeutics initiated with a Buy at Jefferies

Medium Report

Oruka Therapeutics initiated with a Buy at Jefferies

Report

10/27

08:06 am

orka

Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.

Medium Report

Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.

Report

10/27

08:06 am

orka

Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.

Medium Report

Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.

Report

10/27

08:05 am

orka

Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.

Medium Report

Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.

Report

10/27

07:52 am

orka

Rating for ORKA

Low Report

Rating for ORKA

Report

10/27

07:52 am

orka

Rating for ORKA

Low Report

Rating for ORKA

Report

10/27

06:26 am

orka

Oruka Therapeutics initiated with a Buy at Guggenheim

Low Report

Oruka Therapeutics initiated with a Buy at Guggenheim

Report

10/27

06:26 am

orka

Oruka Therapeutics initiated with a Buy at Guggenheim

Low Report

Oruka Therapeutics initiated with a Buy at Guggenheim

Report

10/14

07:59 am

orka

Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Medium Report

Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Report

10/13

08:06 am

orka

Rating for ORKA

Low Report

Rating for ORKA

Report

10/13

08:06 am

orka

Rating for ORKA

Low Report

Rating for ORKA

Report

10/13

05:25 am

orka

Oruka Therapeutics initiated with an Overweight at Barclays

Low Report

Oruka Therapeutics initiated with an Overweight at Barclays

Report

10/13

05:25 am

orka

Oruka Therapeutics initiated with an Overweight at Barclays

Low Report

Oruka Therapeutics initiated with an Overweight at Barclays

Report

9/29

08:05 am

orka

Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.

High Report

Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $56.00 price target on the stock.

Report

9/29

06:20 am

orka

Rating for ORKA

High Report

Rating for ORKA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.